Evidence map›Paper›PMID 42507756›Full record

ArticlePLoS computational biology2026

Quantitative analysis of massive SARS-CoV-2 testing in the community in France in 2021-2022 reveals the associations of variant, vaccination, and age with viral dynamics in symptomatic individuals.

Maxime Beaulieu, Nathanaël Hozé, Vincent Vieillefond, Timothée Goetschy, Gina Cosentino, François Blanquart, Florence Débarre, Jérémie Guedj

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maxime BeaulieuUniversité Paris Cité, Inserm, IAME, Paris, France.ORCID https://orcid.org/0009-0003-1758-8146
Nathanaël HozéUniversité Paris Cité, Inserm, IAME, Paris, France.ORCID https://orcid.org/0000-0002-3977-8966
Vincent VieillefondBiogroup Paris Ouest, Levallois-Perret, France.
Timothée GoetschySCM Biogroup, Levallois-Perret, France.
Gina CosentinoSCM Biogroup, Levallois-Perret, France.
François BlanquartCentre interdisciplinaire de recherche en biologie, Collège de France, Paris, France.
Florence DébarreInstitute of Ecology and Environmental Sciences Paris (IEES Paris), Sorbonne Université, CNRS, IRD, INRAE, Paris, France.ORCID https://orcid.org/0000-0003-2497-833X
Jérémie GuedjUniversité Paris Cité, Inserm, IAME, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has shown the value of large-scale community PCR tests for epidemic surveillance, but the viral load measurements they provide have seldom been exploited to reconstruct within-host trajectories. Because these data are collected for diagnostic rather than research purposes, they are characterized by sparse longitudinal follow-up, heterogeneous sampling, and missing metadata, raising uncertainty about their usefulness to reconstruct with-host viral dynamics. We first conducted a simulation study to assess the feasibility of estimating the viral dynamics patterns from such datasets. Across multiple scenarios replicating realistic sampling patterns, we found that peak viral load and clearance time could be estimated with good accuracy, although uncertainty tended to be underestimated. Parameters driving early viral kinetics, e.g., incubation and proliferation time, were mostly estimated with poor precision, as most community tests are conducted after symptom onset, later in infection. We then applied this framework to a large dataset of 322,218 PCR tests associated with symptomatic SARS-CoV-2 infections in France between July 2021 and March 2022, encompassing both Delta-variant circulation and the emergence of first Omicron variants. We quantified the associations of age, vaccination status, and variant type with viral load trajectories. Age ≥ 65 years was consistently associated with a longer clearance time (2-6 days), while vaccination was associated with a shorter clearance time (2-4 days). Infections with Omicron variants were associated with lower peak viral load (2-3 Ct) and shorter clearance times (1-2 days) compared with pre-Omicron (Delta) infections. Thus, community PCR tests can be leveraged to identify key parameters of viral dynamics. As multiplex PCR testing becomes increasingly widespread, establishing robust frameworks for data collection, sharing, and privacy protection will be essential to support the use of these data for modelling purposes.

Indexed as

COVID-19COVID-19 TestingSARS-CoV-2Age FactorsComputer SimulationCOVID-19 VaccinesFranceHumansVaccinationViral LoadCOVID-19 Vaccines

Identifiers

PMID42507756
PMCPMC13426954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.